About Acta Pharmaceuticals
Acta Pharmaceuticals focused on developing new therapies for early intervention and prevention of Alzheimer's disease.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
Boston, United States
Tracked Since
Oct 16, 2026
Web & Domain Identity
Official Website
actapharmaceuticals.com
Domain Registered Date
Nov 4, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $24,000,000 · Seed
Backed by Alzheimer's Research Foundation, Dolby Family Ventures
- Milestone
Website domain registered
actapharmaceuticals.com
Investors & Backers
Alzheimer's Research Foundation
Dolby Family Ventures
Gamma Biosciences
Funding History
Seed equity
· Oct 15, 2026
Round backers: Alzheimer's Research Foundation, Dolby Family Ventures, Gamma Biosciences
$24,000,000 citybiz.co
Founders & Leadership
Rudolph E. Tanzi
Scientific Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026